In the last trading session, 2.06 million shares of the Perspective Therapeutics Inc (AMEX:CATX) were traded, and its beta was 1.12. Most recently the company’s share price was $3.61, and it changed around $0.44 or 13.88% from the last close, which brings the market valuation of the company to $267.96M. CATX currently trades at a discount to its 52-week high of $16.55, offering almost -358.45% off that amount. The share price’s 52-week low was $1.60, which indicates that the current value has risen by an impressive 55.68% since then.
Perspective Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.14. If we narrow it down even further, the data shows that 0 out of 14 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 1 recommended CATX as a Hold, whereas 10 deemed it a Buy, and 0 rated it as Underweight.
Perspective Therapeutics Inc (AMEX:CATX) trade information
Instantly CATX has showed a green trend with a performance of 13.88% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.70 on recent trading dayincreased the stock’s daily price by 2.43%. The company’s shares are currently up 13.17% year-to-date, but still up 11.76% over the last five days. On the other hand, Perspective Therapeutics Inc (AMEX:CATX) is 49.79% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $21, which translates to bulls needing to increase their stock price by 82.81% from its current value. Analyst projections state that CATX is forecast to be at a low of $3 and a high of $24.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -9.86%. Perspective Therapeutics Inc earnings are expected to increase by 6.46% in 2025, but the outlook is negative -1.94% per year for the next five years.
CATX Dividends
Perspective Therapeutics Inc’s next quarterly earnings report is expected to be released in July.
